Risk factors for avascular bone necrosis in systemic lupus erythematosus

British Journal of Rheumatology

Volumn 37, Issue 8, 1998, Pages 895-900

  Mok, C C ^a   Lau, C S ^a   Wong, R W S ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Avascular bone necrosis; Complication; Corticosteroid; Lupus anticoagulant; Musculoskeletal

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; AVASCULAR NECROSIS; BONE SCINTISCANNING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CUSHINGOID SYNDROME; DISEASE PREDISPOSITION; FEMALE; HIGH RISK PATIENT; HUMAN; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031851207     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.8.895     Document Type: Article

References (20)

1. Abeles M, Urman JD, Rothfield N. Aseptic necrosis of bone in systemic lupus erythematosus. Arch Intern Med 1978;138:750-4.
2. Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. J Am Med Assoc 1960;174:966-8.
3. Zizic TM. Avascular necrosis of bone. Curr Opin Rheumatol 1990;2:26-37.
4. Asherson RA, Liote F, Page B et al. Avascular necrosis of bone and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1995;20:284-8.
5. Nagasawa K, Ishii Y, Mayumi T et al. Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities. Ann Rheum Dis 1989; 48:672-6.
6. Mont MA, Fairbank AC, Petri M, Hungerford DS. Core decompression of osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Orthop 1997;334: 91-7.
7. Tan EM, Cohen AS, Fries JS et al. 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D et al. Sensitivity to change of 3 systemic lupus erythematosus disease activity indices: international validation. J Rheumatol 1994;21:1468-71.
9. Mont MA, Glueck CJ, Pacheco IH et al. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol 1997;24:654-62.
10. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: An update. Arthritis Care Res 1995;8:137-45.
11. Smith FE, Sweet DE, Brunner CM, Davis JS IV. Avascular necrosis in systemic lupus erythematosus. An apparent predilection for young adults. Ann Rheum Dis 1976;35: 227-32.
12. Dimant J, Ginzler EM, Diamond HS et al. Computer analysis of factors influencing the appearance of aseptic necrosis in patients with systemic lupus erythematosus. J Rheumatol 1978;5:136-41.
13. Bergstein JM, Wiens P, Fish AJ, Vernier RL, Michael A. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. J Paediatr 1974;85:31-5.
14. Massardo E, Jacobelli S, Leissner M et al. High dose intravenous methylprednisolone therapy associated with osteonecrosis in patients with systemic lupus erythematosus. Lupus 1992;1:401-5.
15. Migliaresi S, Picillo U, Ambrosone L et al. Avascular osteonecrosis in patients with systemic lupus erythematosus: relation to corticosteroid therapy and anticardiolipin antibodies. Lupus 1994;3:37-41.
16. Leventhal GH, Dorfman HD. Aseptic necrosis of bone in systemic lupus erythematosus. Semin Arthritis Rheum 1974;4:73-93.
17. Velayos EE, Lordholt JD, Smyth CJ, Priest R. Arthroplasty associated with steroid therapy. Ann Intern Med 1966;64:759-71.
18. Mok CC, Lau CS, Cheng PW, Ip WY. Bilateral Kienbock's disease in systemic lupus erythematosus. Scand J Rheumatol 1997;26:485-7.
19. Zizic TM, Marcoux C, Hungerford DS, Dansereau J-Y, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med 1985;79:596-604.
20. Klipper AR, Stevens MB, Zizic TM, Hungerford DS. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore) 1976;55:251-7.